Cross-platform expression microarray performance in a mouse model of mitochondrial disease therapy.

Abstract

UNLABELLED Microarray expression profiling has become a valuable tool in the evaluation of the genetic consequences of metabolic disease. Although 3'-biased gene expression microarray platforms were the first generation to have widespread availability, newer platforms are gradually emerging that have more up-to-date content and/or higher cost efficiency… (More)
DOI: 10.1016/j.ymgme.2009.10.179

Topics

7 Figures and Tables

Slides referencing similar topics